FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

18072011000001101: Doxazosin 2mg tablets (Fannin (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Nov 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
142681000001119 Doxazosin 2mg tablets (Fannin (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
142691000001117 Doxazosin 2mg tablets (Fannin (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62160101000001115 Doxazosin 2mg tablets (Neolab Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
62160201000001110 Doxazosin 2mg tablets (Neolab Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
66282301000001119 Doxazosin 2mg tablets (Fannin UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxazosin 2mg tablets (Fannin (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Is a Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Has active ingredient Doxazosin mesilate false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Has specific active ingredient Doxazosin mesilate true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Fannin (UK) Ltd) Has basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Doxazosin 2mg tablets (Fannin (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP True Doxazosin 2mg tablets (Fannin (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start